Global Biologics Outsourcing Market Size and Growth Analysis | Forecast 2026 to 2035 By Type (Antibody, Recombinant, Protein, Vaccines, Others), Application (Vaccine & Therapeutics Development, Blood & Blood Related Products Testing, Cellular and Gene Therapy, Other)
January 2026
Information and Technology
Pages: 120
ID: MRS2037
The Biologics Outsourcing Market was valued at USD million in 2025, reflecting a CAGR of % from 2026 to 2035. It is projected to grow to USD million by 2035.
Global Biologics Outsourcing Market Overview:
Therapeutic entities that are composed of sugars, proteins, or nucleic acids are known as biologics. They are made form natural sources such as humans, animals, or microorganisms. Biologics inculcate live attenuated microorganisms (vaccines), allergenic extracts (allergy shots), human cells and tissues (transplantation), gene therapies and cell therapies. Biologics are proposed to treat diseases and medical conditions, just like small molecule drugs. However, biologics are highly specific to the treatment of a disease or a condition as biologic entities like recombinant proteins and monoclonal antibodies target precise areas in the molecular mechanism of disease action.
Even though biologics are costlier as compared to small molecule drugs, these classes of drugs prove to be highly beneficial for the patient owing to the specificity of treatment and also bring more profit for the manufacturers. The global biologics outsourcing market is anticipated to gain a strong growth trajectory over the forecast period.
This biologics outsourcing market report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2020 to 2035.
Biologics Outsourcing Market Segmentation:
The global biologics outsourcing market is segmented by type, region, and application for a detailed understanding of the market scenario. This aids in better decision making capabilities and better clarity of the landscape. By type, the market segments included in the report are antibody, recombinant, protein, vaccines, others. Based on application, the report has included segments of vaccine & therapeutics development, blood & blood related products testing, cellular and gene therapy, other.
Market Segment By Type:
Type-wise breakup of the global biologics outsourcing market
- Antibody
- Recombinant
- Protein
- Vaccines
- Others
By Application:
Application-wise breakup of the global biologics outsourcing market
- Vaccine & Therapeutics Development
- Blood & Blood Related Products Testing
- Cellular and Gene Therapy
- Other
Biologics Outsourcing Market: Regional Analysis
The biologics outsourcing market is segmented on the basis of geography into:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
The global biologics outsourcing market is studied for the regional segments of Asia Pacific, Europe, North America, South America and the Middle East & Africa. North America is anticipated to garner the largest share of the global biologics outsourcing market. this can be accredited to the increasing research funding for genomics research and elevation in the number of pharmaceutical and biotechnology companies. Demand for biologics is anticipated to upsurge in North America owing as compared to small molecule drugs, which is credited to the benefits offered to the patients. Asia Pacific is expected to hold the second-largest market share for biologics outsourcing.
North America Biologics Outsourcing Market Revenue And Forecasts TO 2035
The North America Regional and Country-level Revenue And Forecast Analysis:
North America Biologics Outsourcing Industry Overview
North America Biologics Outsourcing Industry Forecasts and Analysis
North America Biologics Outsourcing Industry Forecasts and Analysis - By Type
North America Biologics Outsourcing Industry Forecasts and Analysis - By Application
North America Biologics Outsourcing Industry Forecasts and Analysis - By Countries
United States Biologics Outsourcing Market
United States Biologics Outsourcing by Type
United States Biologics Outsourcing by Application
Canada Biologics Outsourcing Market
Canada Biologics Outsourcing by Type
Canada Biologics Outsourcing by Application
Mexico Biologics Outsourcing Market
Mexico Biologics Outsourcing by Type
Mexico Biologics Outsourcing by Application
Europe Biologics Outsourcing Market Revenue And Forecasts TO 2035
The Europe Regional and Country-level Revenue And Forecast Analysis:
Europe Biologics Outsourcing Industry Overview
Europe Biologics Outsourcing Industry Forecasts and Analysis
Europe Biologics Outsourcing Industry Forecasts and Analysis - By Type
Europe Biologics Outsourcing Industry Forecasts and Analysis - By Application
Europe Biologics Outsourcing Industry Forecasts and Analysis - By Countries
Germany Biologics Outsourcing Market
Germany Biologics Outsourcing by Type
Germany Biologics Outsourcing by Application
France Biologics Outsourcing Market
France Biologics Outsourcing by Type
France Biologics Outsourcing by Application
Italy Biologics Outsourcing Market
Italy Biologics Outsourcing by Type
Italy Biologics Outsourcing by Application
United Kingdom Biologics Outsourcing Market
United Kingdom Biologics Outsourcing by Type
United Kingdom Biologics Outsourcing by Application
Rest of Europe Biologics Outsourcing Market
Rest of Europe Biologics Outsourcing by Type
Rest of Europe Biologics Outsourcing by Application
Asia-Pacific Biologics Outsourcing Market Revenue And Forecasts TO 2035
The Asia-Pacific Regional and Country-level Revenue And Forecast Analysis:
Asia-Pacific Biologics Outsourcing Industry Overview
Asia-Pacific Biologics Outsourcing Industry Forecasts and Analysis
Asia-Pacific Biologics Outsourcing Industry Forecasts and Analysis - By Type
Asia-Pacific Biologics Outsourcing Industry Forecasts and Analysis - By Application
Asia-Pacific Biologics Outsourcing Industry Forecasts and Analysis - By Countries
Australia Biologics Outsourcing Market
Australia Biologics Outsourcing by Type
Australia Biologics Outsourcing by Application
China Biologics Outsourcing Market
China Biologics Outsourcing by Type
China Biologics Outsourcing by Application
India Biologics Outsourcing Market
India Biologics Outsourcing by Type
India Biologics Outsourcing by Application
Japan Biologics Outsourcing Market
Japan Biologics Outsourcing by Type
Japan Biologics Outsourcing by Application
South Korea Biologics Outsourcing Market
South Korea Biologics Outsourcing by Type
South Korea Biologics Outsourcing by Application
Rest of Asia-Pacific Biologics Outsourcing Market
Rest of Asia-Pacific Biologics Outsourcing Market by Type
Rest of Asia-Pacific Biologics Outsourcing Market by Application
(Note: Rest of all the regions mentioned in this report will be presented using the above-mentioned parameters.)
Competitive Landscape
This report profiles key players in the global biologics outsourcing market based on the following parameters, company overview, key facts, business description, financial overview (sales quantity, revenue, price, gross margin), products and services, geographical presence, SWOT analysis, and key developments. These companies collectively hold the largest market share and dictate industry trends. The following are the leading companies in the Boehringer Ingelheim, Catalent, GenScript, Innovent Biologics, Syngene, Shanghai Medicilon, GL Biochem Corporation, GVK Biosciences Private, Horizon Discovery Group, Selexis, Lonza, Abzena, Adimab
Company Profiles:
Major Companies Covered in the biologics outsourcing market:
- Boehringer Ingelheim
- Catalent
- GenScript
- Innovent Biologics
- Syngene
- Shanghai Medicilon
- GL Biochem Corporation
- GVK Biosciences Private
- Horizon Discovery Group
- Selexis
- Lonza
- Abzena
- Adimab
Biologics Outsourcing Market Scope
| Report Attribute | Details |
| Report Objective | To provide comprehensive insights into the biologics outsourcing market size, trends, segmentation, regional dynamics, and competitive landscape. |
| Base Year | 2025 |
| Historical Period | 2020 to 2024 |
| Forecast Period | 2026 to 2035 |
| Market Size In 2025 | USD million |
| Market Size In 2035 | USD million |
| Compound Annual Growth Rate (CAGR) | % |
| Segments |
By Product Type
Antibody, Recombinant, Protein, Vaccines, Others
By Application
Vaccine & Therapeutics Development, Blood & Blood Related Products Testing, Cellular and Gene Therapy, Other |
| Regions Covered |
|
| Companies Profiled | Boehringer Ingelheim, Catalent, GenScript, Innovent Biologics, Syngene, Shanghai Medicilon, GL Biochem Corporation, GVK Biosciences Private, Horizon Discovery Group, Selexis, Lonza, Abzena, Adimab |
Frequently Asked Questions
Related Reports
Recent Reports
Global Animation and VFX Design Software Market Size and Growth Analysis 2020 to 2025 | Forecast 2026 to 2035
Global Animation and VFX Design Software Market is valued at USD million in 2025 and has witnessed a CAGR of % during 2020-2025. The market is anticipated to further register a CAGR of over % during the forecast period of 2026 to 2035
Global Anti-Asthmatics and COPD Drugs Market Size and Growth Analysis 2020 to 2025 | Forecast 2026 to 2035
Global Anti-Asthmatics and COPD Drugs Market is valued at USD million in 2025 and has witnessed a CAGR of % during 2020-2025. The market is anticipated to further register a CAGR of over % during the forecast period of 2026 to 2035